Ranbezolid
Chemical compound
Clinical data | |
---|---|
Other names | RBX-7644 |
Identifiers | |
| |
PubChem CID |
|
ChemSpider |
|
ChEMBL |
|
CompTox Dashboard (EPA) |
|
Chemical and physical data | |
Formula | C21H24FN5O6 |
Molar mass | 461.450 g·mol−1 |
3D model (JSmol) |
|
| |
InChI
|
Ranbezolid (RBx7644) is an oxazolidinone antibacterial. It competitively inhibits monoamine oxidase-A (MAO-A).[1]
References
- ^ Naruganahalli KS, Shirumalla RK, Bansal V, Gupta JB, Das B, Ray A (September 2006). "Ranbezolid, a novel oxazolidinone antibacterial: in vivo characterisation of monoamine oxidase inhibitory potential in conscious rats". European Journal of Pharmacology. 545 (2–3): 167–72. doi:10.1016/j.ejphar.2006.06.065. PMID 16899241.
- v
- t
- e
Aminoglycosides (initiation inhibitors) |
| ||||||
---|---|---|---|---|---|---|---|
Tetracycline antibiotics (tRNA binding) |
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This systemic antibiotic-related article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e